U.S. Surgeon General Says We Need to Reconsider How We Schedule Marijuana
U.S. Surgeon General Jerome Adams says we should look into how we schedule marijuana, and that its current schedule hinders medical research.
“Just as we need to look at criminal justice laws, rules and regulations, we need to look at health laws, rules and regulations, and that includes the scheduling system,” said Adams during a recent question and answer session at a Police Assisted Addiction Recovery Initiative conference. “I’ll take it somewhere else: marijuana. We need to look at the way we schedule different medications across the board, because one of the concerns that I have with marijuana is the difficulty that the folks have to do research on it, because of the scheduling system.”
Currently marijuana is a schedule 1 drug, meaning it has absolutely no medical value; other schedule 1 drugs include heroin, LSD and MDMA. Marijuana’s status as a schedule 1 drug makes it almost impossible for most researchers to study it in a comprehensive and unbiased manner.
Adams was nominated by President Trump to become the 20th U.S. Surgeon General in June of last year; he was confirmed by the Senate in August, and took over the position the following month. Prior to his current position, Adams served as the Indiana State Health Commissioner.